Who
In numbers
- Trades disclosed
- 51
- Buys
- 2
- Sells
- 23
- Bought
- $10K
- Sold
- $10.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 Apr 2012
- Last trade
- 8 Jan 2026
- Last filed
- 9 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jan 2026filed 9 Jan 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 8 Jan 2026filed 9 Jan 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 29 Jan 2025filed 30 Jan 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —87,500 at $0.00 | filing |
| 6 Jan 2025filed 7 Jan 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $286K10,021 at $28.53 | filing |
| 3 Jan 2025filed 7 Jan 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $343K11,337 at $30.29 | filing |
| 5 Jan 2024filed 5 Jan 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 3 Jan 2024filed 5 Jan 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $809K47,867 at $16.91 | filing |
| 15 Dec 2023filed 14 Feb 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —40,000 at $0.00 | filing |
| 2 Jun 2023filed 5 Jun 2023 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $2.0M73,647 at $26.70 | filing |
| 12 Mar 2023filed 14 Mar 2023 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 20 Jul 2022filed 22 Jul 2022 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 20 Jul 2022filed 22 Jul 2022 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 5 Jan 2022filed 7 Jan 2022 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $177K9,653 at $18.31 | filing |
| 4 Jan 2022filed 7 Jan 2022 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.4M75,312 at $19.20 | filing |
| 18 Jun 2021filed 22 Jun 2021 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 30 Dec 2020filed 4 Jan 2021 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 21 Dec 2020filed 12 Feb 2021 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —7,000 at $0.00 | filing |
| 9 Oct 2020filed 12 Feb 2021 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —125,000 at $0.00 | filing |
| 16 Jul 2020filed 20 Jul 2020 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Jul 2020filed 20 Jul 2020 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
News
TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026TGTX · simcoereformer.ca · 8 Oct 2026
0 headlines in the last 90 days name Sean A. Power; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.